Oxford Biomedica Buys US Manufacturing Facility For $4.5M
Biotech company Oxford Biomedica said Tuesday that it has acquired a viral-vector manufacturing facility in North Carolina from biopharmaceutical company Resilience for $4.5 million, expanding the British company's footprint in the...To view the full article, register now.
Already a subscriber? Click here to view full article